Orange Book product · Generic (ANDA)
NINTEDANIB ESYLATE
NINTEDANIB ESYLATE
Generic (ANDA)ANDA 219227TE ABRX APOTEX
At a glance
Apr 02, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 02, 2026
3 mo ago
Today
Pharmaceutical detail
Active ingredient
NINTEDANIB ESYLATE
Strength
EQ 100MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 219227
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NINTEDANIB ESYLATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
